1
|
Leung PYM, Katerelos M, Choy S, Cook N, Lee M, Paizis K, Abboud A, Manning JA, Mount PF, Power DA. Expression of NEDD4L and ENaC in Urinary Extracellular Vesicles in Pre-eclampsia. Hypertens Pregnancy 2023; 42:2232029. [PMID: 37417251 DOI: 10.1080/10641955.2023.2232029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 07/08/2023]
Abstract
OBJECTIVE To assess changes in expression of renal epithelial sodium channel (ENaC) and NEDD4L, a ubiquitin ligase, in urinary extracellular vesicles (UEV) of pre-eclamptic women compared to normal pregnant controls. METHODS Urine was collected from pre-eclamptic women (PE, n = 20) or during normal pregnancy (NP, n = 20). UEV were separated by differential ultracentrifugation. NEDD4L, α-ENaC and γ-ENaC were identified by immunoblotting. RESULTS There was no difference in the expression of NEDD4L (p = 0.17) and α-ENaC (p = 0.10). PE subjects showed increased expression of γ-ENaC by 6.9-fold compared to NP (p < 0.0001). CONCLUSION ENaC expression is upregulated in UEV of pre-eclamptic subjects but was not associated with changes in NEDD4L.
Collapse
Affiliation(s)
- P Y M Leung
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia
- Department of Nephrology, Austin Health, Heidelberg, Australia
- Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia
| | - M Katerelos
- Department of Nephrology, Austin Health, Heidelberg, Australia
- Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia
| | - S Choy
- Department of Nephrology, Austin Health, Heidelberg, Australia
| | - N Cook
- Department of Nephrology, Austin Health, Heidelberg, Australia
| | - M Lee
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia
- Department of Nephrology, Austin Health, Heidelberg, Australia
- Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia
| | - K Paizis
- Department of Nephrology, Austin Health, Heidelberg, Australia
| | - A Abboud
- Department of Obstetrics & Gynaecology, Mercy Hospital for Women, Heidelberg, Australia
| | - J A Manning
- Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia
| | - P F Mount
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia
- Department of Nephrology, Austin Health, Heidelberg, Australia
- Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia
| | - D A Power
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia
- Department of Nephrology, Austin Health, Heidelberg, Australia
- Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia
| |
Collapse
|
2
|
Ellis R, Katerelos M, Choy SW, Cook N, Lee M, Paizis K, Pell G, Walker S, Power DA, Mount PF. Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia. J Transl Med 2019; 17:60. [PMID: 30819197 PMCID: PMC6394033 DOI: 10.1186/s12967-019-1806-6] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2018] [Accepted: 02/21/2019] [Indexed: 12/13/2022] Open
Abstract
Background Glycolysis is altered in various kidney diseases, but little is known about glycolysis in pre-eclampsia, a multi-system disorder with major pathological effects on the kidney. Urinary exosomes provide a non-invasive alternative for studying changes in kidney metabolism. This study aims to characterise the expression and phosphorylation of isozymes of the key glycolytic regulatory protein, 6-phosphofructokinase-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2), in urinary exosomes of subjects with pre-eclampsia (PE), compared to normotensive non-pregnant (NC) and normotensive pregnant (NP) controls. Methods A cross-sectional study of NC (n = 19), NP (n = 23) and PE (n = 29) subjects was performed. Exosomes were isolated from urine samples by differential ultracentrifugation, and then analyzed by Western blot and densitometry for expression of PFK-2/FBPase-2 isozymes (PFKFB2, PFKFB3 and PFKFB4) and phosphorylation of PFKFB2 at residues Ser483 and Ser466 and PFKFB3 at Ser461. Results PFKFB2 expression was increased 4.7-fold in PE compared to NP (p < 0.001). PFKFB2 phosphorylation at Ser483 was increased 2.6-fold in PE compared to NP (p = 0.002). Expression of phosphorylated PFKFB2/PFKFB3 at Ser466/Ser461 was increased in PE, being present in 77.4% (95% CI 59.9–88.9%) of PE and 8.3% (95% CI 1.2–27.0%) of NP samples (p < 0.001). PFKFB3 was more commonly expressed in PE, detected in 90.3% (95% CI 74.3–97.4%) of PE and 8.3% (95% CI 1.2–27.0%) of NP samples (p < 0.001). PFKFB4 had a 7.2-fold increase in expression in PE compared to NP (p < 0.001). No significant differences between NP and NC groups were observed. Conclusion Regulatory proteins that increase glycolysis are increased in the urinary exosomes of subjects with pre-eclampsia, suggesting that renal glycolysis may be increased in this condition.
Collapse
Affiliation(s)
- R Ellis
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.,Department of Nephrology, Austin Health, Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia
| | - M Katerelos
- Department of Nephrology, Austin Health, Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia.,Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia
| | - S W Choy
- Department of Nephrology, Austin Health, Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia
| | - N Cook
- Department of Nephrology, Austin Health, Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia
| | - M Lee
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.,Department of Nephrology, Austin Health, Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia.,Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia
| | - K Paizis
- Department of Nephrology, Austin Health, Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia
| | - G Pell
- Mercy Hospital for Women, Heidelberg, Australia
| | - S Walker
- Mercy Hospital for Women, Heidelberg, Australia
| | - D A Power
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia.,Department of Nephrology, Austin Health, Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia.,Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia
| | - P F Mount
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia. .,Department of Nephrology, Austin Health, Studley Road, Heidelberg, Melbourne, VIC, 3084, Australia. .,Kidney Laboratory, Institute for Breathing and Sleep, Heidelberg, Australia.
| |
Collapse
|
4
|
Lee D, Gleich K, Fraser SA, Katerelos M, Mount PF, Power DA. Limited capacity of proximal tubular proteolysis in mice with proteinuria. Am J Physiol Renal Physiol 2013; 304:F1009-19. [PMID: 23344573 DOI: 10.1152/ajprenal.00601.2012] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Albuminuria is associated with the additional loss in the urine of small molecular weight proteins normally degraded by the proximal convoluted tubule (PCT), and competition for binding to the megalin/cubilin reuptake system has been considered the likely cause. We have previously reported that deficiency of the intrinsic lysosomal protein Limp-2 causes tubular proteinuria due to reduced fusion of endosomes with lysosomes in the PCT leading to inadequate proteolysis. To determine whether this mechanism also contributes to the tubular proteinuria induced by albumin overload in normal mice, wild-type (WT) mice received daily BSA injections intraperitoneally for 10 days, using untreated Limp-2(-/-) mice as positive controls for inadequate proteolysis. BSA overload induced significant urinary loss of megalin and cubilin ligands in WT mice. Tubular uptake of Alexa-conjugated BSA, administered by intravenous injection, was not reduced in the PCT of mice receiving intraperitoneal BSA. Expression of the tubular protein receptor megalin was also unchanged. There was a delay in proteolysis of reabsorbed proteins in WT mice receiving BSA, evidenced by an increased quantity of retinol-binding protein (RBP) in the kidney cortex, increased basal distribution of endocytosed RBP in cells of the PCT, and persistence of exogenous Alexa-conjugated BSA and RBP after injection. Upregulation of cathepsin L and normal fusion of lysosomes with endosomes were apparently not sufficient to maintain normal clearance of endocytosed proteins. The data suggest that in the presence of competition from albumin overload, reabsorption of filtered proteins is limited by the capacity of lysosomal degradation rather than receptor-mediated endocytosis.
Collapse
Affiliation(s)
- D Lee
- Department of Nephrology, Austin Health, Studley Rd., Heidelberg, Victoria 3084, Australia.
| | | | | | | | | | | |
Collapse
|
5
|
Abstract
In the kidney nitric oxide (NO) has numerous important functions including the regulation of renal haemodynamics, maintenance of medullary perfusion, mediation of pressure-natriuresis, blunting of tubuloglomerular feedback, inhibition of tubular sodium reabsorption and modulation of renal sympathetic neural activity. The net effect of NO in the kidney is to promote natriuresis and diuresis. Significantly, deficient renal NO synthesis has been implicated in the pathogenesis of hypertension. All three isoforms of nitric oxide synthase (NOS), namely neuronal NOS (nNOS or NOS1), inducible NOS (iNOS or NOS2) and endothelial NOS (eNOS or NOS3) are reported to contribute to NO synthesis in the kidney. The regulation of NO synthesis in the kidney by NOSs is complex and incompletely understood. Historically, many studies of NOS regulation in the kidney have emphasized the role of variations in gene transcription and translation. It is increasingly appreciated, however, that the constitutive NOS isoforms (nNOS and eNOS) are also subject to rapid regulation by post-translational mechanisms such as Ca(2+) flux, serine/threonine phosphorylation and protein-protein interactions. Recent studies have emphasized the role of post-translational regulation of nNOS and eNOS in the regulation of NO synthesis in the kidney. In particular, a role for phosphorylation of nNOS and eNOS at both activating and inhibitory sites is emerging in the regulation of NO synthesis in the kidney. This review summarizes the roles of NO in renal physiology and discusses recent advances in the regulation of eNOS and nNOS in the kidney by post-translational mechanisms such as serine/threonine phosphorylation.
Collapse
Affiliation(s)
- P F Mount
- The Austin Research Institute, Austin Hospital, Victoria, Australia.
| | | |
Collapse
|
6
|
Mount PF, Sutton VR, Li W, Burgess J, McKEnzie IF, Pietersz GA, Trapani JA. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice. Cancer Res 1994; 54:6160-6. [PMID: 7954462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The mouse monoclonal antibody, m30.6 (IgG2b), detects an antigenic determinant expressed predominantly on the surface of colorectal adenocarcinoma cells and has been shown previously to be a potentially useful therapeutic and diagnostic reagent for human colon cancer. We report the production and characterization of a mouse/human chimeric antibody, c30.6, with potent in vitro and in vivo antitumor activity. The genes encoding the variable domains for heavy and light chains were amplified by thermal cycling using degenerate oligonucleotide primers complementary to conserved immunoglobulin framework sequences. The gene segments were sequenced, subcloned into eukaryotic expression vectors containing human constant region genes (IgG1 and kappa), and cotransfected into nonsecreting Sp2/0 mouse myeloma cells. There were significant differences in the biological activities of the murine and chimeric antibodies. The i.p. administration of c30.6 but not of m30.6 produced a marked growth inhibition of s.c. 30.6+ COLO 205 tumors in scid/scid mice (approximately 40% reduction in tumor size, measured 21 days after tumor inoculation). Reduced tumor growth was not due to altered binding characteristics of c30.6 because: (a) the chimeric antibody was shown by flow cytometry to bind exclusively to cell lines that expressed the 30.6 determinant; (b) c30.6 was able to completely inhibit the binding of m30.6 on 30.6+ cells; and (c) the affinity of binding of the two antibodies was the same (Ka, approximately 1.50 x 10(8)). Up to 15% of the total injected antibody dose/g tissue was localized in 30.6+ tumors at 24 h, approximately 13% was present in the tumors at 48 h, and approximately 10% was present at 72 h. Furthermore, c30.6 demonstrated a shorter circulating half-life (53 h; m30.6, 72 h) when given i.p. to C57BL6 x BALB/cF1 mice. Unlike m30.6, c30.6 was also strongly active in antibody-dependent cell-mediated cytotoxicity against a range of 30.6+ tumor target cells in vitro. Up to 80% specific 51Cr release was achieved using either freshly isolated human peripheral blood mononuclear cells or 2-day-old interleukin 2-stimulated human peripheral blood mononuclear cells as effectors. The enhanced antitumor activity of c30.6 suggests that it might be a useful immunotherapeutic reagent for colorectal carcinoma.
Collapse
MESH Headings
- Adenocarcinoma/immunology
- Adenocarcinoma/therapy
- Amino Acid Sequence
- Animals
- Antibodies, Monoclonal/genetics
- Antibodies, Monoclonal/metabolism
- Antibodies, Monoclonal/therapeutic use
- Antibodies, Neoplasm/genetics
- Antibodies, Neoplasm/metabolism
- Antibodies, Neoplasm/therapeutic use
- Antibody Affinity
- Antibody-Dependent Cell Cytotoxicity
- Base Sequence
- Colorectal Neoplasms/immunology
- Colorectal Neoplasms/therapy
- Humans
- Immunoglobulin Variable Region/genetics
- Mice
- Mice, Inbred BALB C
- Mice, Inbred CBA
- Mice, SCID
- Molecular Sequence Data
- Neoplasm Transplantation
- Recombinant Fusion Proteins/metabolism
- Recombinant Fusion Proteins/therapeutic use
- Transplantation, Heterologous
Collapse
Affiliation(s)
- P F Mount
- Austin Research Institute, Austin Hospital, Heidelberg, Australia
| | | | | | | | | | | | | |
Collapse
|